Bietti Crystalline Dystrophy (BCD) Overview
Learn About Bietti Crystalline Dystrophy (BCD)
Bietti crystalline dystrophy is a disorder in which numerous small, yellow or white crystal-like deposits of fatty (lipid) compounds accumulate in the light-sensitive tissue that lines the back of the eye (the retina). The deposits damage the retina, resulting in progressive vision loss.
Bietti crystalline dystrophy is caused by mutations in the CYP4V2 gene. This gene provides instructions for making a member of the cytochrome P450 family of enzymes. These enzymes are involved in the formation and breakdown of various molecules and chemicals within cells. The CYP4V2 enzyme is involved in a multi-step process called fatty acid oxidation in which lipids are broken down and converted into energy, but the enzyme's specific function is not well understood. CYP4V2 gene mutations that cause Bietti crystalline dystrophy impair or eliminate the function of this enzyme and are believed to affect lipid breakdown. However, it is unknown how they lead to the specific signs and symptoms of Bietti crystalline dystrophy. For unknown reasons, the severity of the signs and symptoms differs significantly among individuals with the same CYP4V2 gene mutation.
Bietti crystalline dystrophy has been estimated to occur in 1 in 67,000 people. It is more common in people of East Asian descent, especially those of Chinese and Japanese background. Researchers suggest that Bietti crystalline dystrophy may be underdiagnosed because its symptoms are similar to those of other eye disorders that progressively damage the retina.
This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.
Massachusetts Eye And Ear Associates, Inc
Sherleen Chen is an Ophthalmologist in Boston, Massachusetts. Dr. Chen and is rated as an Advanced provider by MediFind in the treatment of Bietti Crystalline Dystrophy (BCD). Her top areas of expertise are Cataract, Glaucoma, Amblyopia, Cataract Removal, and Trabeculectomy.
Massachusetts Eye And Ear Associates, Inc
Scott Greenstein is an Ophthalmologist in Boston, Massachusetts. Dr. Greenstein and is rated as an Advanced provider by MediFind in the treatment of Bietti Crystalline Dystrophy (BCD). His top areas of expertise are Glaucoma, Cataract, Optic Atrophy Type 1, Optic Nerve Atrophy, and Cataract Removal.
Massachusetts Eye And Ear Associates, Inc
Lucia Sobrin is an Ophthalmologist and a General Surgeon in Boston, Massachusetts. Dr. Sobrin and is rated as an Advanced provider by MediFind in the treatment of Bietti Crystalline Dystrophy (BCD). Her top areas of expertise are Uveitis, Diabetic Retinopathy, Scleritis, Vitrectomy, and Cataract Removal.
Summary: This is a multi-center, randomized and controlled phase 3 clinical trial.
Published Date: November 01, 2012
Published By: National Institutes of Health